TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response.

Fatima Karzai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.